NDC 68788-7944-09 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-7944
- Requested NDC
- 68788-7944-09
- Package NDCs from labels
- 68788-7944-3, 68788-7944-9, 68788-7944-1, 68788-7944-09
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-05-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-05-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-7944-1 | Levothyroxine sodium | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 68788-7944-3 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 68788-7944-9 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-7944 | LEVOTHYROXINE SODIUM TABLET [PREFERRED PHARMACEUTICALS INC.] | 4 | Current NDC, Legacy NDC, 3 package rows | 20240615_6d65b528-f52b-4b5d-8b76-46fbd4576f99.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-7944-1 | EA - Each | 68788-7944 | ef7bcfba-95f5-48d0-a9d1-3a2b2fb5210f | 1 | 2022-11-07 |
| 68788-7944-3 | EA - Each | 68788-7944 | 5cc87cee-623c-4d3b-8419-6b2a8c05247e | 1 | 2022-11-07 |
| 68788-7944-9 | EA - Each | 68788-7944 | 3e3dcb50-8a70-4b88-9d10-3f02548f9d1b | 1 | 2022-11-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | bc9385d0-5c67-4bde-94da-e621347e2cba | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 4c903249-69e9-4168-a9d1-22e6c2c1eb22 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966220 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 6f25cbb3-0358-4778-b8f0-f76479a2dcc5 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 7fd988be-ab3d-406d-a55d-1e5a8a2101cc | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 6108759a-783e-42ca-b078-6a3cd84ce901 | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 13e03769-9a4f-497f-9afa-95bf525090b3 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NorthStar RxLLC | 58f4dc90-3648-49dc-a7e1-baf918a773b5 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 966224 966249 966220 966225 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 597ea445-d926-adc6-e063-6394a90a6446 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| PNV Prenatol | MULTIVITAMIN | PureTek Corporation | 583f0194-0306-f31b-e063-6394a90a2a10 | 2026-08-06 | Warnings, Adverse reactions | 3A3U0GI71G |
| PRENATE Restore | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, BIOTIN, CALCIUM CARBONATE, FERROUS FUMARATE, MAGNESIUM OXIDE, LACTIC ACID AND DOCONEXENT | Avion Pharmaceuticals, LLC | 1076ba9a-0168-492f-ba9b-99fa02186092 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 3A3U0GI71G |
| PNV-Omega | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CORBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM, DOCONEXENT, ICOSAPENT | Acella Pharmaceuticals, LLC | 735c5531-137f-4cee-8c68-ae121045a8ff | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 55f4c679-86cb-b97f-e063-6294a90ad5ef | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 55f67831-4680-edbf-e063-6294a90a1d36 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Magnesium Oxide | MAGNESIUM OXIDE | Westminster Pharmaceuticals, LLC | 52eeac0e-94bb-48c3-81dc-578e96406c01 | 2026-07-06 | Warnings | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 489ffba8-983e-478f-8f62-fe08bf3d0e0b | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Vitramyn | FOLIC ACID | PureTek Corporation | c8af7616-5178-6df0-e053-2a95a90a334d | 2026-06-18 | Warnings, Adverse reactions | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 544d67eb-8487-cb5d-e063-6394a90a3110 | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Prenate Mini | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, LEVOMEFOLATE CALCIUM, CYANOCOBALAMIN, BIOTIN, CALCIUM CARBONATE, FERROUS ASPARTO GLYCINATE, IRON, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT AND LOWBUSH BLUEBERRY | Avion Pharmaceuticals, LLC | 8ab766c2-d554-4141-92b2-fbe038e80c9f | 2026-06-12 | Boxed warning, Adverse reactions | 3A3U0GI71G |
| Prenate Essential | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, LEVOMEFOLATE CALCIUM, CYANOCOBALAMIN, BIOTIN, CALCIUM FORMATE, FERROUS ASPARTO GLYCINATE, POTASSIUM IODIDE, MAGNESIUM OXIDE, DOCONEXENT AND ICOSAPENT | Avion Pharmaceuticals, LLC | e5acfb2a-0959-4542-9b4c-790be194d581 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | 3A3U0GI71G |
| Prenate Elite | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, LEVOMEFOLATE CALCIUM, CALCIUM FORMATE, FERROUS ASPARTO GLYCINATE, CYANOCOBALAMIN, BIOTIN, POTASSIUM IODIDE, MAGNESIUM OXIDE, ZINC OXIDE AND CUPRIC OXIDE | Avion Pharmaceuticals, LLC | 9b79c950-4312-4a53-9e36-fb8e00b053df | 2026-06-12 | Boxed warning, Adverse reactions | 3A3U0GI71G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.